We suggest that efforts to more clearly confirm or identify the direct receptor of SPINK1, and the mechanism by which it influences EGFR signaling, could lead to identification of novel points for therapeutic intervention in cancers that express SPINK1. This evidence concerns the gene EGFR and cancer.